Clinical trial
A Comparison of Study Drug With Placebo and Haloperidol in Patients With Schizophrenia
NCT00044044
Study timeline
Study start (unknown)2002-07-01Date precision: month
Registry last updated2014-04-17
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Schizophreniaunresolved
Interventions
Sponsors & collaborators
Sumitomo Pharma America, Inc.lead sponsor
Mapped research locations
San DiegoCalifornia, United States3PhiladelphiaPennsylvania, United States2DallasTexas, United States2AustinTexas, United States2AtlantaGeorgia, United States1BirminghamAlabama, United States1CincinnatiOhio, United States1TampaFlorida, United States1Washington D.C.District of Columbia, United States1MilwaukeeWisconsin, United States1OrangeCalifornia, United States1HonoluluHawaii, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00044044 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.